CPH 0.00% 0.9¢ creso pharma limited

Why wouldn't you buy?, page-27

  1. 11,703 Posts.
    lightbulb Created with Sketch. 1077
    The underwriters for the recent SPP would be absolutely made millions on CPH due to the shortfall.

    Now they control a significant shareholding of CPH. Which should minimise distribution selling as compared to SIs. They are maintaining concentration risk.

    Its best CPH management work with the underwriters to sell there shares to institutions via off market transfers at a premium to the current SPP.

    To make this worthwhile for the underwriters they will need a much higher price for CPH than $1.10
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.